# CPT 55700

> Medicare paid $253.37 for CPT 55700 in the office (non-facility) setting and $136.02 in a facility under the Q2 2017 Physician Fee Schedule, effective April 2017. These are the national allowed amounts before the ~2% sequestration cut and before locality (GPCI) adjustment. This price has been unchanged since Q1 2017, when it increased 14.3%.

## What it is

A needle biopsy of the prostate gland — one or more tissue samples taken through a needle or punch — most often performed to evaluate for prostate cancer.

## Selected release

- Release: Q2 2017 (2017 B)
- Effective: April 1 – June 30, 2017
- Status indicator: A
- Office (non-facility) national allowed amount: $253.37
- Facility national allowed amount: $136.02
- Sequestration: not applied

## RVUs and formula

- Work RVU: 2.50
- Office (non-facility) practice expense RVU: 4.28
- Facility practice expense RVU: 1.01
- Malpractice RVU: 0.28
- Conversion factor: 35.8887
- Formula: `(work_rvu × work_gpci + pe_rvu × pe_gpci + mp_rvu × mp_gpci) × conversion_factor`

## Source and citation

- Source: Physician relative value file (Q2 2017)
- CMS file: https://www.cms.gov/medicare/medicare-fee-for-service-payment/physicianfeesched/downloads/rvu17b.zip
- Parsed file: PPRRVU17_V0209.csv, row 10,065
- Canonical page: https://localishealth.com/cpt/55700/2017/A
- Release-specific citation URL: https://localishealth.com/cpt/55700/2017/B
- Last significant update: 2026-08-04T03:07:42+00:00